The protein kinase MEK1/2 mediate vascular endothelial growth factor- and histamine-induced hyperpermeability in porcine coronary venules

Journal of Physiology

Volumn 563, Issue 1, 2005, Pages 95-104

  Wu, Mach H ^a,b   Yuan, Sarah Y ^a   Granger, Harris J ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HISTAMINE; IONOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; VASCULOTROPIN; 8 BROMO CYCLIC GMP; CALCIUM IONOPHORE; CYCLIC GMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA ANALYSIS; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SWINE; VASCULAR ENDOTHELIUM; VENULE; CORONARY VEIN; ENZYME ACTIVATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; VEIN BLOOD FLOW; VEIN PERMEABILITY;

ANIMALS; CAPILLARY PERMEABILITY; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTAMINE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; SIGNAL TRANSDUCTION; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENULES;

EID: 14844323993     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.076075     Document Type: Article

References (61)

1. Alessi DR, Cohen P, Ashworth A, Cowley S, Leevers SJ & Marshall CJ (1995). Assays and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf. Meth Enzymol 255, 279-290.
2. Aramoto H, Breslin JW, Pappas PJ, Hobson RW II & Duran WN (2004). Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation. Am J Physiol Heart Circ Physiol 287, H1590-H1598.
3. Bates DO & Harper SJ (2003). Regulation of vascular permeability by vascular endothelial growth factors. Vascular Pharmacol 39, 225-237.
4. Bates DO, Heald RI, Curry FE & Williams B (2001). Vascular endothelial growth factor increases Rana vascular permeability and compliance by different signalling pathways. J Physiol 533, 263-272.
5. Berra E, Milanini J, Richard DE, Le Gall M, Vinals F, Gothie E, Roux D, Pages G & Pouyssegur J (2000). Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem Pharmacol 60, 1171-1178.
6. Breslin JW, Pappas PJ, Cerveira JJ, Hobson RW & Duran WN (2003). VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol 284, H92-H100.
7. Chang L & Karin M (2001). Mammalian MAP kinase signaling cascades. Nature 410, 37-40.
8. Charest DL, Mordret G, Harder KW, Jirik F & Pelech SL (1993). Molecular cloning, expression, and characterization of the human mitogen activated protein kinase p44 erk 1. Mol Cell Biol 13, 4679-4690.
9. Davies SP, Reddy H, Caivano M & Cohen P (2000). Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351, 95-105.
10. Duzgun SA, Rasque H, Kito H, Azuma N, Li W, Basson MD, Gahtan V, Dudrick SJ & Sumpio BE (2000). Mitogen-activated protein phosphorylation in endothelial cells exposed to hyperosmolar conditions. J Cell Biochem 76, 567-571.
11. Dvorak HF, Nagy JA, Feng D & Brown LF (1999). Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 237, 97-132.
12. Ferrara N & Davis-Smyth T (1997). The biology of vascular endothelial growth factor. Endocr Rev 18, 4-25.
13. Fleming I, Fisslthaler B & Busse R (1995). Calcium signaling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinases. Circ Res 76, 522-529.
14. Garcia JG & Schaphorst KL (1995). Regulation of endothelial cell gap formation and paracellular permeability. J Investig Med 43, 117-126.
15. Gorenne I, Su X & Moreland RS (1998). Inhibition of p42 and p44 MAP kinase does not alter smooth muscle contraction in swine carotid artery. Am J Physiol 275, H131-H138.
16. Haneda M, Sugimoto T & Kikkawa R (1999). Mitogen-activated protein kinase phosphatase: a negative regulator of the mitogen-activated protein kinase cascade. Eur J Pharmacol 365, 1-7.
17. He H, Venema VJ, Gu X, Venema RC, Marrero MB & Caldwell RB (1999). Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem 274, 25130-25135.
18. Hood J & Granger HJ (1998). Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells. J Biol Chem 273, 23504-23508.
19. Hood JD, Meininger CJ, Ziche M & Granger HJ (1998). VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 274, H1054-H1058.
20. Huang Q & Yuan SY (1997). Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability. Am J Physiol 273, H2442-H2451.
21. Huxley VH, Curry FE & Adamson RH (1987). Quantitative fluorescence microscopy on single capillaries: alpha-lactalbumin transport. Am J Physiol 252, H188-H197.
22. Jo H, Sipos K, Go YM, Law R, Rong J & McDonald JM (1997). Differential effect of shear stress on extracellular signal-regulated kinase and N-terminal Jun kinase in endothelial cells. Gi2- and Gbeta/gamma-dependent signaling pathways. J Biol Chem 272, 1395-1401.
23. Katoch SS & Moreland RS (1995). Agonist and membrane depolarization induced activation of MAP kinase in the swine carotid artery. Am J Physiol 269, H222-H229.
24. Kelemen BR, Hsiao K & Goueli SA (2002). Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides. J Biol Chem 10, 8741-8748.
25. 2-mediated permeability: role of MAPK and occludin. Am J Physiol 279, C21-C30.
26. 2+-independent force development in histamine-stimulated bovine tracheal smooth muscle. Br J Pharmacol 131, 981-989.
27. Kyriakis TM & Avruch J (2001). Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81, 807-869.
28. Lal BK, Varma S, Pappas PJ, Hobson RW & Duran WN (2001). VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric oxide synthase, and MAP kinase pathways. Microvasc Res 62, 252-261.
29. Lampugnani MG, Giorgi M, Baboli M, Dejana E & Marchisio PC (1990). Endothelial cell motility, integrin receptor clustering, and microfilament organization are inhibited by agents that increase intracellular cAMP. Lab Invest 63, 521-531.
30. Liu F, Verin AD, Borbiev T & Garcia JG (2001). Role of cAMP-dependent protein kinase A activity in endothelial cell cytoskeleton rearrangement. Am J Physiol 280, L1309-L1317.
31. Lum H, Jaffe HA, Schulz IT, Masood A, RayChaudhury A & Green RD (1999). Expression of PKA inhibitor (PKI) gene abolishes cAMP-mediated protection to endothelial barrier dysfunction. Am J Physiol 277 C580-C588.
32. Lum H & Malik AB (1994). Regulation of vascular endothelial barrier function. Am J Physiol 267, L223-L241.
33. Marks RM, Roche WR, Czerniecki M, Penny R & Nelson DS (1986). Mast cell granules cause proliferation of human microvascular endothelial cells. Lab Invest 55, 289-294.
34. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F & Ziche M (1996). Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 270, H411-H415.
35. Moy AB, Winter M, Kamath A, Blackwell K, Reyes G, Giaever I, Keese C & Shasby DM (2000). Histamine alters endothelial barrier function at cell-cell and cell-matrix sites. Am J Physiol Lung Cell Mol Physiol 278, L888-L898.
36. Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A & Isner JM (1998). Vascular endothelial growth factor /vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97, 99-107.
37. 1/2 activation in postcapillary endothelium. J Biol Chem 273, 4220-4226.
38. Parenti A, Morbidelli L, Ledda F, Granger HJ & Ziche M (2001). The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway. FASEB J 15, 1487-1489.
39. Pearson G, Robinson F, Gibson TB, Xu B, Karandikar M, Berman K & Cobb MH (2001). Mitogen-activated protein (MAP) kinase pathways: regulation and physiological function. Endocr Rev 22, 153-183.
40. Rissanen TT, Markkanen JE, Arve K, Rutanen J, Kettunen MI, Vajanto I, Jauhiainen S, Cashion L, Gruchala M, Narvanen O, Taipale P, Kauppinen RA, Rubanyi GM & Yla-Herttuala S (2003). Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model. FASEB J 17, 100-102.
41. Robinson AJ & Dickenson JM (2001). Activation of the p38 and p42/p44 mitogen-activated protein kinase families by the histamine H1 receptor in DDT(1)MF-2 cells. Br J Pharmacol 133, 1378-1386.
42. Siflinger-Birnboim A & Johnson A (2003). Protein kinase C modulates pulmonary endothelial permeability: a paradigm for acute lung injury. Am J Physiol Lung Cell Mol Physiol 284, L435-L451.
43. Takahashi T, Ueno H & Shibuya M (1999). VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 18, 2221-2230.
44. Tinsley JH, Hawker J & Yuan Y (1998). Efficient protein transfection of cultured coronary venular endothelial cells. Am J Physiol 275, H1873-H1878.
45. Tinsley JH, Zawieja DC, Ustinova EE, Wu MH, Xu W & Yuan SY (2001). Protein transfection of intact microvessels specifically modulates vasoreactivity and permeability. J Vas Res 38, 444-452.
46. Traub O, Monia BP, Dean NM & Berk BC (1997). PKC-epsilon is required for mechano-sensitive activation of ERK1/2 in endothelial cells. J Biol Chem 272, 31251-31257.
47. van Nieuw Amerongen GP, van Delft S, Vermeer MA, Collard JG & van Hinsbergh VW (2000). Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases. Circ Res 87, 335-340.
48. Varma S, Breslin JW, Lal BK, Pappas PJ, Hobson RW & Duran WN (2002). p42/44MAPK regulates baseline permeability and cGMP-induced hyperpermeability in endothelial cells. Microvasc Res 63, 172-178.
49. Verin AD, Liu F, Bogatcheva N, Borbiev T, Hershenson MB, Wang P & Garcia JG (2000). Role of ras-dependent ERK activation in phorbol ester-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 279, L360-L370.
50. Wheeler-Jones CP & Pearson JD (1995). Thrombin and histamine phosphorylated the 42kDa mitogen-activated protein kinase in HUVEC. Biochem Soc Trans 23, 203S.
51. Wu MH, Guo M, Yuan SY & Granger HJ (2003). Focal adhesion kinase mediates porcine venular hyperpermeability elicited by vascular endothelial growth factor. J Physiol 552, 691-699.
52. Wu HM, Huang Q, Yuan Y & Granger HJ (1996). VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol 271, H2735-H2739.
53. Wu HM, Yuan Y, Zawieja DC, Tinsley J & Granger HJ (1999). Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. Am J Physiol 276, H535-H542.
54. Yuan SY (2000). Signal transduction pathways in enhanced microvascular permeability. Microcirculation 7, 395-403.
55. Yuan Y, Chilian WM, Granger HJ & Zawieja DC (1993a). Permeability to albumin in isolated coronary venules. Am J Physiol 265, H543-H552.
56. Yuan Y, Granger HJ, Zawieja DC & Chilian WM (1992). Flow modulates venular permeability by a nitric oxide-related mechanism. Am J Physiol 263, H641-H646.
57. Yuan Y, Granger HJ, Zawieja DC, DeFily DV & Chilian WM (1993b). Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am J Physiol 264, H1734-H1739.
58. Zachary I & Gliki G (2001). Signal transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 49, 568-581.
59. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P & Ledda F (1994). Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94, 2036-2044.
60. Ziche M, Morbidelli L, Masini E, Granger HJ, Geppetti P & Ledda F (1993a). Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem Biophys Res Commun 192, 1198-1203.
61. Ziche M, Morbidelli L, Parenti A, Amerini S, Granger HJ & Maggi CA (1993b). Substance P increases cyclic GMP levels on coronary postcapillary venular endothelial cells. Life Sci 53 PL229-PL234.